News

Biogen Inc. has entered into a definitive agreement with TJ Biopharma to acquire exclusive rights to the investigational drug felzartamab in the Greater China region, completing its…
Read More...

Eli Lilly and Company and Kelonia Therapeutics, Inc. ("Kelonia"), a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for…
Read More...

UCB has announced a definitive agreement to acquire Neurona Therapeutics in a deal aimed at strengthening its epilepsy portfolio and expanding into regenerative medicine. The…
Read More...

The European Commission has granted approval to ENFLONSIA, a preventive therapy developed by Merck & Co., for protecting newborns and infants against respiratory syncytial virus…
Read More...

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a strategic collaboration aimed at strengthening capabilities in the rapidly growing field of antibody-drug…
Read More...

Interna Therapeutics has entered into a new research collaboration with Daiichi Sankyo to explore next-generation approaches to intracellular drug delivery, marking another step forward…
Read More...

Nucleai and Sirona Dx have announced a strategic partnership aimed at delivering a fully integrated spatial proteomics solution to pharmaceutical and biotechnology companies. The…
Read More...

Terremoto Biosciences has secured $108 million in a Series C financing round, strengthening its position in the race to develop next-generation targeted therapies for cancer and rare…
Read More...

Aligos Therapeutics has entered into an exclusive licensing agreement with Xiamen Amoytop Biotech Co., Ltd. to develop and commercialize its investigational hepatitis B treatment,…
Read More...

Boehringer Ingelheim and Zai Lab have announced a new clinical collaboration aimed at advancing a novel dual-targeting strategy for difficult-to-treat cancers. The partnership will…
Read More...

Sana Biotechnology has announced a strategic collaboration with Mayo Clinic to accelerate the development of SC451, an investigational cell therapy aimed at transforming treatment for…
Read More...

CrossBridge Bio, Inc., a pre-clinical biotech firm specializing in next-generation antibody-drug conjugates (ADCs), has agreed to be acquired by Eli Lilly and Company in a deal valued…
Read More...

Replimune Group has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration for its Biologics License Application (BLA) seeking approval of RP1 in…
Read More...

Telix Pharmaceuticals and Regeneron Pharmaceuticals have announced a strategic collaboration to jointly develop and commercialize next-generation radiopharmaceutical therapies, marking…
Read More...

AbbVie has announced encouraging late-breaking results from its Phase 2 IMGN853-0420 clinical trial, showcasing the potential of mirvetuximab soravtansine-gynx in treating recurrent…
Read More...

Daiichi Sankyo and Merck & Co. (known as MSD outside the United States and Canada) have announced that the U.S. Food and Drug Administration has accepted and granted Priority Review…
Read More...

Novo Nordisk has announced a strategic partnership with OpenAI aimed at transforming healthcare through advanced artificial intelligence, with a focus on accelerating drug discovery and…
Read More...

Telix Pharmaceuticals Limited has announced that the U.S. Food and Drug Administration has accepted its resubmitted New Drug Application (NDA) for TLX101-Px, an investigational imaging…
Read More...

C4 Therapeutics, Inc. has announced a new collaboration agreement with Roche to advance research in a promising cancer treatment approach known as degrader-antibody conjugates (DACs).…
Read More...

AC Immune SA has strengthened its long-standing partnership with Eli Lilly and Company through an amendment to their 2018 collaboration agreement, advancing efforts to develop novel…
Read More...